Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Xeris Biopharma Holdings Inc (NASDAQ: XERS) closed at $4.73 in the last session, up 1.50% from day before closing price of $4.66. In other words, the price has increased by $1.50 from its previous closing price. On the day, 1.47 million shares were traded. XERS stock price reached its highest trading level at $4.77 during the session, while it also had its lowest trading level at $4.52.
Ratios:
We take a closer look at XERS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.72.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.Craig Hallum initiated its Buy rating on August 28, 2023, with a $4.50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 13 ’25 when McCulloch Kevin bought 25,000 shares for $4.38 per share. The transaction valued at 109,475 led to the insider holds 1,708,585 shares of the business.
Fairley Ricki Louise bought 56,667 shares of XERS for $277,668 on May 09 ’25. On Mar 20 ’25, another insider, Hecht Beth, who serves as the insider of the company, sold 40,000 shares for $5.43 each. As a result, the insider received 217,244 and left with 1,353,510 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 757533184 and an Enterprise Value of 958234880. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.40. Its current Enterprise Value per Revenue stands at 4.306 whereas that against EBITDA is -221.148.
Stock Price History:
The Beta on a monthly basis for XERS is 0.69, which has changed by 1.2417061 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $6.07, while it has fallen to a 52-week low of $2.03. The 50-Day Moving Average of the stock is 1.85%, while the 200-Day Moving Average is calculated to be 21.92%.
Shares Statistics:
According to the various share statistics, XERS traded on average about 2.39M shares per day over the past 3-months and 2215120 shares per day over the past 10 days. A total of 156.01M shares are outstanding, with a floating share count of 147.58M. Insiders hold about 7.85% of the company’s shares, while institutions hold 54.43% stake in the company. Shares short for XERS as of 1749772800 were 17940320 with a Short Ratio of 7.49, compared to 1747267200 on 17803095. Therefore, it implies a Short% of Shares Outstanding of 17940320 and a Short% of Float of 11.66.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
